<VariationArchive RecordType="classified" VariationID="870631" VariationName="NM_201280.3(BLOC1S5):c.345del (p.Val116fs)" VariationType="Deletion" Accession="VCV000870631" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-06-05" DateCreated="2020-10-10" MostRecentSubmission="2021-02-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="858793" VariationID="870631">
      <GeneList>
        <Gene Symbol="BLOC1S5" FullName="biogenesis of lysosomal organelles complex 1 subunit 5" GeneID="63915" HGNC_ID="HGNC:18561" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="8013567" stop="8064414" display_start="8013567" display_stop="8064414" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="8013799" stop="8064646" display_start="8013799" display_stop="8064646" Strand="-" />
          </Location>
          <OMIM>607289</OMIM>
        </Gene>
        <Gene Symbol="BLOC1S5-TXNDC5" FullName="BLOC1S5-TXNDC5 readthrough (NMD candidate)" GeneID="100526836" HGNC_ID="HGNC:42001" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="7881250" stop="8064414" display_start="7881250" display_stop="8064414" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="EEF1E1-BLOC1S5" FullName="EEF1E1-BLOC1S5 readthrough (NMD candidate)" GeneID="100526837" HGNC_ID="HGNC:49187" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="8013567" stop="8102595" display_start="8013567" display_stop="8102595" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_201280.3(BLOC1S5):c.345del (p.Val116fs)</Name>
      <CanonicalSPDI>NC_000006.12:8026405:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="8026406" stop="8026406" display_start="8026406" display_stop="8026406" variantLength="1" positionVCF="8026405" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="8026639" stop="8026639" display_start="8026639" display_stop="8026639" variantLength="1" positionVCF="8026638" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>Muted</Name>
      </OtherNameList>
      <ProteinChange>Q72fs</ProteinChange>
      <ProteinChange>V116fs</ProteinChange>
      <ProteinChange>V52fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.8026639del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.8026639del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.8026406del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.8026406del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037616.1" sequenceAccession="NR_037616" sequenceVersion="1" change="n.383del">
            <Expression>NR_037616.1:n.383del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037618.1" sequenceAccession="NR_037618" sequenceVersion="1" change="n.691del">
            <Expression>NR_037618.1:n.691del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199322.1" sequenceAccession="NM_001199322" sequenceVersion="1" change="c.153del">
            <Expression>NM_001199322.1:c.153del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001186251.1" sequenceAccession="NP_001186251" sequenceVersion="1" change="p.Val52fs">
            <Expression>NP_001186251.1:p.Val52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199323.1" sequenceAccession="NM_001199323" sequenceVersion="1" change="c.215del">
            <Expression>NM_001199323.1:c.215del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001186252.1" sequenceAccession="NP_001186252" sequenceVersion="1" change="p.Gln72fs">
            <Expression>NP_001186252.1:p.Gln72fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201280.3" sequenceAccession="NM_201280" sequenceVersion="3" change="c.345del" MANESelect="true">
            <Expression>NM_201280.3:c.345del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958437.1" sequenceAccession="NP_958437" sequenceVersion="1" change="p.Val116fs">
            <Expression>NP_958437.1:p.Val116fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="607289.0002" DB="OMIM" />
        <XRef Type="rs" ID="1763106978" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_201280.3(BLOC1S5):c.345del (p.Val116fs) AND Hermansky-Pudlak syndrome" Accession="RCV001260551" Version="1">
        <ClassifiedConditionList TraitSetID="6264">
          <ClassifiedCondition DB="MedGen" ID="C0079504">Hermansky-Pudlak syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-04-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_201280.3(BLOC1S5):c.345del (p.Val116fs) AND Hermansky-Pudlak syndrome 11" Accession="RCV001290298" Version="1">
        <ClassifiedConditionList TraitSetID="65255">
          <ClassifiedCondition DB="MedGen" ID="C5436936">Hermansky-Pudlak syndrome 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-01-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-01-29" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-10-10" MostRecentSubmission="2021-02-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32565547</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6264" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2033" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome/3391" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019312" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
                <XRef ID="9311003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6643" />
                <XRef ID="6643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C0079504" DB="MedGen" />
              <XRef ID="MONDO:0019312" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="65255" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33254" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 11</ElementValue>
                <XRef ID="MONDO:0030903" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS11</ElementValue>
                <XRef Type="MIM" ID="619172" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <XRef ID="C5436936" DB="MedGen" />
              <XRef ID="MONDO:0030903" DB="MONDO" />
              <XRef Type="MIM" ID="619172" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2467173" SubmissionDate="2020-05-05" DateLastUpdated="2020-10-10" DateCreated="2020-10-10">
        <ClinVarSubmissionID localKey="SUB7267982" submittedAssembly="GRCh37" title="SUB7267982" />
        <ClinVarAccession Accession="SCV001197996" DateUpdated="2020-10-10" DateCreated="2020-10-10" Type="SCV" Version="1" SubmitterName="Laboratoire de Genetique Moleculaire, Centre Hospitalier Universitaire de Bordeaux" OrgID="506590" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-09">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>One patient harbored a homozygous 1 bp deletion in exon 4 of BLOC1S5, NM_201280.2:c.345del p.(Val116Serf19*). ACMG classification is in favor of a pathogenic variant (PVS1, PS4, PM2). She had pigmented skin, blond hair and brown iris, and numerous pigmented naevi. She had mild ocular albinism including nystagmus, grade 1 retinal hypopigmentation, iris transillumination, optic nerve decussation anomalies on visual evoked potentials, strabismus, photophobia, and visual acuity of 6/10 on both eyes. The fovea was normal (Figure 2). Clinical report indicated important epistaxis, mostly in childhood, easy or unexplained bruising, menorrhagia improved by contraception, excessive blood loss after deliveries, surgery and dental extraction, as well as abdominal pain, dyspnea, and recurrent infections (pneumonia, herpes, conjunctivitis). These features suggested a syndromic form of albinism. Functionnal analysis of another LOF variant in BLOC1S5 are in favor of the involvment of BLOC1S5 in a new form of Hermansky-Pudlak Syndrome : HPS11.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001022" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001934" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BLOC1S5">
              <Name>biogenesis of lysosomal organelles complex 1 subunit 5</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_201280.2:exon 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>Muted</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_201280.2:c.345del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0079504" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7267982</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2914420" SubmissionDate="2021-01-29" DateLastUpdated="2021-02-07" DateCreated="2021-02-07">
        <ClinVarSubmissionID localKey="607289.0002_HERMANSKY-PUDLAK SYNDROME 11" title="BLOC1S5, 1-BP DEL, NT345_HERMANSKY-PUDLAK SYNDROME 11" />
        <ClinVarAccession Accession="SCV001478329" DateUpdated="2021-02-07" DateCreated="2021-02-07" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-29">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 39-year-old Slovenian woman with mild oculocutaneous albinism and a bleeding diathesis (HPS11; 619172), Pennamen et al. (2020) identified homozygosity for a 1-bp deletion (c.345del, NM_201280.2) in exon 4 of the BLOC1S5 gene, causing a frameshift predicted to result in a premature termination codon (Val116SerfsTer19). Parental DNA was unavailable for segregation analysis.</Attribute>
              <Citation>
                <ID Source="PubMed">32565547</ID>
              </Citation>
              <XRef DB="OMIM" ID="619172" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BLOC1S5" />
          </GeneList>
          <Name>BLOC1S5, 1-BP DEL, NT345</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, NT345</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607289.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HERMANSKY-PUDLAK SYNDROME 11</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2914420" TraitType="Disease" MappingType="Name" MappingValue="HERMANSKY-PUDLAK SYNDROME 11" MappingRef="Preferred">
        <MedGen CUI="C5436936" Name="Hermansky-Pudlak syndrome 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2467173" TraitType="Disease" MappingType="Name" MappingValue="Hermansky-Pudlak syndrome" MappingRef="Preferred">
        <MedGen CUI="C0079504" Name="Hermansky-Pudlak syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2467173" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001934" MappingRef="HP">
        <MedGen CUI="C1844374" Name="Persistent bleeding after trauma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2467173" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001022" MappingRef="HP">
        <MedGen CUI="C0001916" Name="Albinism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

